Showing results (241-250 of 447) with videos related to

Sort By:
Pageof 45
Future Oncology (London, England)|June 11, 2024
Zolbetuximab plus chemotherapy for locally advanced unresectable or metastatic stomach or gastroesophageal junction cancers: a plain language summaryKohei Shitara, Manish A Shah, Florian Lordick, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 29, 2022
Heterogeneity and evolution of tumour immune microenvironment in metastatic gastroesophageal adenocarcinomaWei Wang, Liu-Fang Ye, Hua Bao, et al.
Hepatology (Baltimore, Md.)|July 21, 2018
A Coiled-Coil Domain Containing 50 Splice Variant Is Modulated by Serine/Arginine-Rich Splicing Factor 3 and Promotes Hepatocellular Carcinoma in Mice by the Ras Signaling PathwayHong Wang, Chris Zhiyi Zhang, Shi-Xun Lu, et al.
BMC Cancer|September 4, 2014
Reduced expression of p21-activated protein kinase 1 correlates with poor histological differentiation in pancreatic cancerJuan Han, Feng Wang, Shu-qiang Yuan, et al.
Stem Cell Research & Therapy|October 17, 2015
Metabolic activation of mitochondria in glioma stem cells promotes cancer development through a reactive oxygen species-mediated mechanismShuqiang Yuan, Yunxin Lu, Jing Yang, et al.
Cancer Medicine|February 8, 2019
Correlation between immune signature and high-density lipoprotein cholesterol level in stage II/III colorectal cancerYun Wang, Xiao-Qiang Sun, Hao-Cheng Lin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 11, 2014
Nutrition support can bring survival benefit to high nutrition risk gastric cancer patients who received chemotherapyMiaozhen Qiu, Yi-xin Zhou, Yin Jin, et al.
The Lancet. Gastroenterology & Hepatology|October 9, 2021
Efficacy and safety of weekly paclitaxel with or without ramucirumab as second-line therapy for the treatment of advanced gastric or gastroesophageal junction adenocarcinoma (RAINBOW-Asia): a randomised, multicentre, double-blind, phase 3 trialRui-Hua Xu, Yanqiao Zhang, Hongming Pan, et al.
Experimental & Molecular Medicine|June 27, 2022
LncRNA TMPO-AS1 promotes esophageal squamous cell carcinoma progression by forming biomolecular condensates with FUS and p300 to regulate TMPO transcriptionXiao-Jing Luo, Ming-Ming He, Jia Liu, et al.
International Journal of Cancer|June 5, 2019
Prospective observation: Clinical utility of plasma Epstein-Barr virus DNA load in EBV-associated gastric carcinoma patientsMiao-Zhen Qiu, Cai-Yun He, Shi-Xun Lu, et al.
Pageof 45